Related Experiment Video
Updated: Jun 27, 2026
06:16
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Canadian quality indicators for percutaneous coronary interventions
Dennis T Ko1, Harindra C Wijeysundera, Xiaofu Zhu
1Institute for Clinical Evaluative Sciences, Ontario, Canada. dennis.ko@ices.on.ca
The Canadian Journal of Cardiology
|December 5, 2008
Summary
A national expert panel developed 26 quality indicators for percutaneous coronary intervention (PCI) in Canada. These indicators will help improve care quality and patient outcomes for PCI procedures nationwide.
Area of Science:
- Cardiovascular Medicine
- Health Services Research
- Quality Improvement Science
Background:
- Adherence to quality indicators directly measures healthcare quality and supports improvement initiatives.
- Currently, no established quality indicators exist for percutaneous coronary intervention (PCI) in Canada.
Purpose of the Study:
- To establish a comprehensive set of quality and outcome indicators for PCI applicable across Canada.
Main Methods:
- A 12-member national expert panel convened, representing diverse Canadian regions.
- A modified Delphi process, including literature review and consensus meetings, was used to identify and refine indicators.
Main Results:
- 26 indicators were identified: 6 structure, 9 process, and 11 outcome indicators.
- Key indicators include medication use (aspirin, clopidogrel, statins), procedure volume, door-to-balloon time, contrast nephropathy prevention, patient education, and post-PCI outcomes (death, MI, revascularization, complications).
Conclusions:
- A novel set of PCI quality indicators tailored for the Canadian healthcare system has been created.
- Implementing these indicators will identify practice gaps, drive quality improvement, and optimize patient outcomes for PCI in Canada.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...